This article relies largely or entirely on a single source . Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Ortho-DOT" – news · newspapers · books · scholar · JSTOR (November 2022) |
| | |
| Clinical data | |
|---|---|
| Other names | 4,5-Dimethoxy-2-methylthioamphetamine; 2-Methylthio-4,5-dimethoxyamphetamine; 2-Thio-TMA-2 |
| Routes of administration | Oral [1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown [1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H19NO2S |
| Molar mass | 241.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Ortho-DOT, also known as 4,5-dimethoxy-2-methylthioamphetamine or as 2-thio-TMA-2, is a drug. [1] Ortho-DOT was first synthesized by Alexander Shulgin. [1] In his book PiHKAL (Phenethylamines i Have Known And Loved) , neither the dose nor the duration are known. [1] Ortho-DOT produces few to no effects. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Ortho-DOT. [1]
| | This psychoactive drug-related article is a stub. You can help Wikipedia by adding missing information. |